- Home
- RKDA vs INM Comparison
RKDA vs INM Comparison
Compare RKDA & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RKDA
- INM
- Stock Information
- Founded
- RKDA 2002
- INM 1981
- Country
- RKDA United States
- INM Canada
- Employees
- RKDA N/A
- INM N/A
- Industry
- RKDA Agricultural Chemicals
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- RKDA Industrials
- INM Health Care
- Exchange
- RKDA Nasdaq
- INM Nasdaq
- Market Cap
- RKDA 5.8M
- INM 5.1M
- IPO Year
- RKDA 2015
- INM N/A
- Fundamental
- Price
- RKDA $5.02
- INM $2.20
- Analyst Decision
- RKDA
- INM
- Analyst Count
- RKDA 0
- INM 0
- Target Price
- RKDA N/A
- INM N/A
- AVG Volume (30 Days)
- RKDA 1.6M
- INM 125.1K
- Earning Date
- RKDA 11-11-2025
- INM 11-13-2025
- Dividend Yield
- RKDA N/A
- INM N/A
- EPS Growth
- RKDA N/A
- INM N/A
- EPS
- RKDA N/A
- INM N/A
- Revenue
- RKDA $5,407,000.00
- INM $4,942,633.00
- Revenue This Year
- RKDA $21.31
- INM N/A
- Revenue Next Year
- RKDA $28.33
- INM N/A
- P/E Ratio
- RKDA N/A
- INM N/A
- Revenue Growth
- RKDA 23.79
- INM 7.50
- 52 Week Low
- RKDA $2.53
- INM $1.72
- 52 Week High
- RKDA $10.31
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- RKDA 63.75
- INM 49.07
- Support Level
- RKDA $3.30
- INM $2.12
- Resistance Level
- RKDA $5.72
- INM $2.24
- Average True Range (ATR)
- RKDA 0.55
- INM 0.13
- MACD
- RKDA 0.17
- INM -0.00
- Stochastic Oscillator
- RKDA 51.46
- INM 41.31
About RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.